Marco Auprich

Summary

Country: Austria

Publications

  1. ncbi External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome
    Marco Auprich
    Department of Urology, Medical University Graz, Austria
    Eur Urol 58:727-32. 2010
  2. ncbi Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
    Marco Auprich
    Department of Urology, Medical University of Graz, Graz, Austria
    Eur Urol 60:1045-54. 2011
  3. ncbi Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    BJU Int 110:363-8. 2012
  4. ncbi Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging
    Marco Auprich
    Department of Urology, Medizinische Universitat Graz, Graz, Austria
    Eur Urol 59:96-105. 2011
  5. ncbi A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
    Marco Auprich
    Department of Urology Pathology, Medical University Graz, Graz, Austria
    BJU Int 109:1627-35. 2012
  6. ncbi Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    Wien Klin Wochenschr 118:348-54. 2006
  7. ncbi Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    Eur J Cancer 46:2235-41. 2010
  8. ncbi Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients
    Richard E Zigeuner
    Department of Urology, University Hospital, Karl Franzens University Graz, Graz, Austria
    Urology 62:451-5. 2003
  9. ncbi Diagnostic yield of touch imprint cytology of prostate core needle biopsies
    Sebastian Mannweiler
    Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, A 8036, Graz, Austria
    Pathol Oncol Res 15:97-101. 2009

Detail Information

Publications9

  1. ncbi External validation of urinary PCA3-based nomograms to individually predict prostate biopsy outcome
    Marco Auprich
    Department of Urology, Medical University Graz, Austria
    Eur Urol 58:727-32. 2010
    ..Prior to safely adopting risk stratification tools, their performance must be tested in an external patient cohort...
  2. ncbi Contemporary role of prostate cancer antigen 3 in the management of prostate cancer
    Marco Auprich
    Department of Urology, Medical University of Graz, Graz, Austria
    Eur Urol 60:1045-54. 2011
    ..Newly discovered biomarkers ideally should prove clinical usefulness, provide additional detection, staging, and prognosis information to improve individual risk assessment, and potentially permit targeted cancer therapy...
  3. ncbi Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    BJU Int 110:363-8. 2012
    ..To analyse the overall accuracy of Partin tables, with special emphasis to potential limitations resulting from differences between prostate cancers detected by different biopsy schedules...
  4. ncbi Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging
    Marco Auprich
    Department of Urology, Medizinische Universitat Graz, Graz, Austria
    Eur Urol 59:96-105. 2011
    ..Knowledge about the staging significance of the prostate cancer antigen 3 (PCA3) score to better identify pathologic features after radical prostatectomy (RP) is limited and controversial...
  5. ncbi A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy
    Marco Auprich
    Department of Urology Pathology, Medical University Graz, Graz, Austria
    BJU Int 109:1627-35. 2012
    ..While the novel diagnostic marker would have avoided a considerable number of unnecessary biopsies in the first repeat biopsy scenario, its effects dissipated at second and ≥ third repeat biopsies...
  6. ncbi Shift of tumor features in patients with clinically localized prostate cancer undergoing radical prostatectomy since the beginning of the PSA era
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    Wien Klin Wochenschr 118:348-54. 2006
    ..To analyze trends of clinical and tumor characteristics over a 12-year period since the beginning of the prostate-specific antigen (PSA) era in a consecutive series of radical prostatectomies...
  7. ncbi Head to head comparison of three generations of Partin tables to predict final pathological stage in clinically localised prostate cancer
    Herbert Augustin
    Department of Urology, Medical University of Graz, Graz, Austria
    Eur J Cancer 46:2235-41. 2010
    ..To perform a head to head comparison between three generations of Partin tables, namely from 1997, 2001 and the last updated version of 2007...
  8. ncbi Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients
    Richard E Zigeuner
    Department of Urology, University Hospital, Karl Franzens University Graz, Graz, Austria
    Urology 62:451-5. 2003
    ..In the pre-PSA era, the diagnosis of incidental carcinoma was exclusively based on normal digital rectal examination (DRE) findings...
  9. ncbi Diagnostic yield of touch imprint cytology of prostate core needle biopsies
    Sebastian Mannweiler
    Institute of Pathology, Medical University of Graz, Auenbruggerplatz 25, A 8036, Graz, Austria
    Pathol Oncol Res 15:97-101. 2009
    ..We conclude, that in problematic cases the additional use of touch imprint cytology and serial sectioning of prostate core needle biopsies significantly improve the diagnostic accuracy...